OPCH Option Care Health, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1014739 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.0%
TTM net income YoY2.9%
TTM EPS YoY8.7%
Revenue 3-yr CAGR11.0%
Net income 3-yr CAGR-5.8%
Margins
Gross margin19.1%
Operating margin5.9%
Net margin3.7%
FCF margin4.9%
EBITDA margin7.1%
Returns
ROE16.0%
ROA6.2%
ROIC (approx.)11.2%
Asset turnover1.65x
Leverage & solvency
Liabilities / assets61.9%
Debt / equity0.87x
Current ratio1.54x
Interest coverage6.39x
Cash quality & payout
Operating cash flow / net income1.50x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.49B | $1.44B | $1.35B | $1.47B | $1.44B | $1.42B | $1.33B | $1.35B |
| Cost of revenue | $1.21B | $1.18B | $1.09B | $1.18B | $1.16B | $1.15B | $1.07B | $539.57M |
| Gross profit | $284.97M | $267.25M | $262.01M | $282.90M | $272.90M | $269.04M | $263.05M | $268.38M |
| SG&A expense | $177.64M | $164.66M | $174.56M | $172.14M | $172.10M | $170.09M | $168.12M | $164.73M |
| Operating income | $89.22M | $85.14M | $72.55M | $91.50M | $84.51M | $82.71M | $79.19M | $87.04M |
| Interest expense | $12.88M | $14.02M | $13.30M | $12.73M | $14.15M | $14.45M | $13.23M | $10.88M |
| Pretax income | $78.90M | $73.99M | $61.00M | $81.52M | $68.97M | $68.86M | $63.56M | $81.05M |
| Income tax | $21.47M | $20.07M | $15.66M | $23.01M | $17.15M | $18.34M | $16.81M | $20.92M |
| Net income | $57.43M | $53.91M | $45.34M | $58.50M | $51.82M | $50.52M | $46.74M | $60.13M |
| EBITDA | $107.34M | $102.59M | $87.45M | $110.76M | $100.80M | $98.95M | $94.93M | $103.65M |
| EPS (basic) | 0.38 | 0.35 | 0.29 | — | 0.32 | 0.31 | 0.28 | — |
| EPS (diluted) | 0.38 | 0.35 | 0.29 | — | 0.32 | 0.31 | 0.28 | — |
| Weighted avg. shares (diluted) | 150.49M | 153.49M | 158.21M | — | 163.09M | 164.13M | 166.80M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $299.09M | $193.77M | $177.32M | $232.62M | $309.82M | $198.82M | $171.37M | $412.56M |
| Receivables | $505.57M | $511.51M | $516.44M | $473.57M | $474.50M | $481.25M | $476.65M | $409.73M |
| Inventory | $408.05M | $399.61M | $415.69M | $471.15M | $415.72M | $403.54M | $369.03M | $388.13M |
| Current assets | $1.31B | $1.20B | $1.20B | $1.26B | $1.28B | $1.18B | $1.10B | $1.32B |
| PP&E, net | $139.03M | $140.41M | $139.94M | $139.24M | $134.30M | $133.67M | $131.26M | $127.37M |
| Goodwill | $1.61B | $1.61B | $1.61B | $1.61B | $1.61B | $1.61B | $1.61B | $1.54B |
| Intangibles | $281.37M | $290.64M | $299.91M | $309.18M | $318.45M | $327.72M | $337.01M | $301.01M |
| Total assets | $3.48B | $3.38B | $3.38B | $3.46B | $3.48B | $3.38B | $3.31B | $3.42B |
| Current liabilities | $850.53M | $819.48M | $729.75M | $829.35M | $823.91M | $773.62M | $713.66M | $780.15M |
| Short-term debt | $6.78M | $6.78M | $6.78M | $6.78M | $6.78M | $6.51M | $6.51M | $6.51M |
| Long-term debt | $1.15B | $1.15B | $1.15B | $1.15B | $1.16B | $1.10B | $1.10B | $1.10B |
| Total debt | $1.16B | $1.16B | $1.16B | $1.16B | $1.16B | $1.11B | $1.11B | $1.11B |
| Total liabilities | $2.15B | $2.12B | $2.03B | $2.13B | $2.12B | $2.02B | $1.96B | $2.02B |
| Shareholders' equity | $1.32B | $1.26B | $1.35B | $1.33B | $1.36B | $1.36B | $1.35B | $1.40B |
| Net debt | $858.74M | $965.05M | $982.50M | $928.21M | $852.01M | $911.39M | $939.30M | $698.59M |
| Shares outstanding | 149.79M | 149.78M | 156.99M | 156.86M | 160.11M | 162.29M | 163.74M | 166.26M |
| Cash flow statement | ||||||||
| Operating cash flow | $114.73M | $183.59M | -$12.11M | $35.89M | $139.44M | $90.33M | -$7.21M | $36.12M |
| Capital expenditure | $6.68M | $11.08M | $9.05M | $13.65M | $9.20M | $9.10M | $9.37M | $10.34M |
| Free cash flow | $108.05M | $172.52M | -$21.16M | $22.25M | $130.24M | $81.24M | -$16.59M | $25.78M |
| Investing cash flow | -$6.68M | -$11.68M | -$9.32M | -$13.65M | -$11.72M | -$9.02M | -$126.69M | -$11.20M |
| Financing cash flow | -$2.72M | -$155.47M | -$33.87M | -$99.44M | -$16.71M | -$53.87M | -$107.29M | -$95.38M |
| Depreciation & amortization | $18.12M | $17.45M | $14.91M | $19.26M | $16.29M | $16.24M | $15.75M | $16.61M |
| Stock-based compensation | $9.33M | $8.38M | $10.20M | $9.32M | $11.12M | $10.71M | $8.80M | $8.52M |
| Share buybacks | $0 | — | — | $95.06M | $62.46M | — | — | $92.60M |
Free plan shows the latest 8 periods; Pro shows all 73 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.